Organ Printing with Melanie Matheu of Prellis Biologics

Organ Printing with Melanie Matheu of Prellis Biologics
Near Frontier
Organ Printing with Melanie Matheu of Prellis Biologics
/
Episode 5 March 16, 2022 00:38:29

Hosted By

Ian Rountree Amee Kapadia Andrew Kirima

Show Notes

We talk to Prellis Biologics founder Melanie Matheu about bioprinting organs with Prellis' holographic laser technology, using bioprinted lymph node organoids for antibody discovery, and Melanie's advice for new bio founders with regards to choosing focus and setting early partnerships. 

Note: We discuss the January 2022 pig-to-human heart transplant at 13:45. This episode was recorded before we learned that the recipient of the transplant has since passed away. 

Get in touch with Prellis—

Prellis Twitter

Melanie's Twitter

Prellis website

Other Episodes

August 24, 2022

The Fourth Pillar of Cancer w/ Anand Parikh of Faeth Therapeutics

Today we're joined by Anand Parikh, founder and CEO of Faeth Therapeutics. Faeth combines precision nutrition, therapeutics, and digital health to deliver a cancer-fighting program designed to deprive tumors of the nutrients they need to grow while providing optimal nutritional support to healthy tissues.  In this episode, we get into what led Anand to start Faeth, dig into the operational complexity behind the business's software, therapeutics, and nutrition aspects, discuss fundraising for an unconventional business model, and more.  Get in touch— Anand's socials Enroll in Faeth's clinical trials here Check out Faeth's open roles here   ...

Play

00:59:58

February 09, 2022

The Deep Tech Decade: Cantos Chats Where Deep Tech is Headed in 2022

Cantos analysts Amee and Andrew dive into their top predictions for what deep tech might see in 2022.  Shownotes: Our 2022 predictions blog post Trailblazer's List by Mina Fahmi: https://trailblazerlist.xyz/ Loonshots by Safi Bahcall Speed & Scale by John Doerr New funding models in biotech Nuclear energy blog post ...

Play

00:29:53

January 25, 2022

RNA Delivery with Anna Perdrix and George Foot of Sixfold Bioscience

Today we're joined by Anna Perdrix Rossell and George Foot of Sixfold Bioscience, co-founders of Sixfold Bioscience, a UK based biotech company using computation and advanced chemistry to engineer highly programmable constructs that make the delivery of RNA therapeutics predictable and precise. Sixfold's technology expands the purview of RNA therapeutics from vaccines to all diseases, starting with cancer. In our conversation, we discuss the challenge of RNA delivery, what it's like starting a biotech company totally from scratch (no academic spinout or venture incubation), how to hire a diverse team, and promising areas of biotechnology.    Shownotes: Get in touch with the Sixfold team: Sixfold Bioscience; George Foot; Anna Perdrix Interested in joining the team? Check out open roles here In this episode, we cover:  Sixfold Bioscience and challenges with RNA delivery  How George and Anna started Sixfold Switching between an academia and entrepreneurship mindset Building a biotech totally from scratch Twitter debate—founder led bio vs venture incubation  Building a diverse (majority women!) team and tips for recruitment Sixfold's big vision Broader trends to be excited about in biotech and deep tech ...

Play

00:43:57